What if a synthetic-biology lab accident sparks a biosecurity crackdown?
A synthetic-bio lab incident is a tail-risk pandemic scare: VIX jumps, crude and distillates sell on mobility fears, gold bids, and the vol spike forces risk-parity deleveraging. Rhymes with the early-COVID Feb-Mar-2020 repricing - the template for a biosecurity demand shock. Skeptic's read: a contained lab incident is far more likely to drive a sentiment/headline spike than an actual pandemic, so the asymmetry favors fading the crude selloff and owning short-dated gold/vol unless transmission is confirmed.
Every number ships with its receipt — the odds, the range, the precedents, and a public grade at Reality Check. The statistical machinery that produces it is proprietary.
The butterfly cascade
How this trigger trickles across markets, left → right — the root shock, its first‑order moves, then the ripple effects. Drag any node; tap a market for its real price history.
Resolution timeline — how this probability is moving
Our model's odds (electric blue) over time vs the market's (Polymarket, amber), from the past toward the 3–10 years horizon. Each dot is a real macro event that nudged the probability — green pushed it up, red pushed it down. Tap a dot for the source. Loading the probability audit trail…
What it would mean
If this plays out, it is a risk-off shock. A synthetic-biology lab incident triggers a biosecurity scare and restrictions. The trigger decomposes into signed root‑shocks — Pandemic shock ▲ · Geopolitical risk ▲ — which propagate through our causal graph to the markets below.